CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 180 enrolled
Drug / intervention
iovera° +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02260921
NCT02260921N/ACompleted

A Multi-Center, Prospective, Double-Blind, Randomized Controlled Study to Evaluate the Effectiveness and Safety of the Iovera° Device for the Temporary Relief of Pain Associated With Knee Osteoarthritis

Pacira Pharmaceuticals, Inc·interventional·Posted Oct 9, 2014·Updated Jan 24, 2024

In Brief

A clinical study evaluating iovera° and Sham Comparator for Knee Osteoarthritis. Completed, enrolled 180 participants across 17 sites.

Detailed Summary

This purpose of this study is to evaluate the effectiveness and safety of the iovera° device for the temporary reduction of pain associated with knee osteoarthritis.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedOct 9, 2014
Enrollment StartOct 20, 2014
Primary CompletionFeb 1, 2016
Study CompletionMay 31, 2016
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 11.7 years ago

Interventions

iovera°device

Sham Comparatordevice